Journal Title:Ebiomedicine
The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
将从生物医学研究中获得的见解有效地转化为改善人类健康是一项全球优先事项。为此,Elsevier 依靠其两个领先品牌 Cell 和 The Lancet 的领导力来指导推出新的综合性、仅限在线开放获取的 Elsevier 期刊 EBioMedicine,该期刊专注于形成一个跨越该界面和为他们各自的受众之间的对话和合作创造了宝贵的机会。
大类学科 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 1区 | 是 | 是 |
大类学科 | 小类学科 | 分区 |
医学 | MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 1区 |
期刊名称 | 领域 | 中科院分区 | 影响因子 |
Developmental Cognitive Neuroscience | 医学 | 1区 | 4.700 |
Circulation-cardiovascular Imaging | 医学 | 1区 | 7.500 |
Annual Review Of Neuroscience | 医学 | 1区 | 13.900 |
Acta Psychiatrica Scandinavica | 医学 | 1区 | 6.700 |
Mmwr Recommendations And Reports | 医学 | 1区 | 33.700 |
Lancet Planetary Health | 医学 | 1区 | 25.700 |